IRF-4 (MUM1p) Antibody sc-56713 from Santa Cruz Biotechnology, Inc.

Product Specs
ItemIRF-4 (MUM1p) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-56713
Antibody TypePrimary Antibodies
NCBI Gene AliasesLSIRF, MUM1, NF-EM5, SHEP8
Quantity250 µl supernatant
CloneMUM1p
ApplicationsWB, IP, IF, IHC(P)
Reactivityhuman
ClonalityMonoclonal
Hostmouse
Conjugate/TagUnconjugated
FormatSupernatant
NCBI Full Gene Nameinterferon regulatory factor 4
IsotypeIgG1
TargetIRF-4

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in micePLoS pathogensApril 1, 2024Bristol JA, Nelson SE, Ohashi M, Casco A, Hayes M, Ranheim EA, Pawelski AS, Singh DR, Hodson DJ, Johannsen EC, et al.(Santa Cruz #sc-514445), anti-IL10Rα (R&D #MAB2742), anti-IL21R (R&D #MAB991), anti-IRF4 (Santa Cruz #sc-56713), anti-JAK1 (Cell Signaling #3332), anti-JAK2 (Cell Signaling #3230), anti-LMP1 (Abcam #ab78113), anti-c-Myb

(2) Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cellsPLoS pathogensApril 1, 2022Bristol JA, Brand J, Ohashi M, Eichelberg MR, Casco A, Nelson SE, Hayes M, Romero-Masters JC, Baiu DC, Gumperz JE, et al.EDPDEETSSQAVKALREMAD), anti-BZLF1 (Santa Cruz #sc-53904), anti-BMRF1 (Millipore #MAB8186), anti-IRF4 (Santa Cruz #sc-56713), anti-EBF1 (Biotechne #AF5165), anti-CD11C (Cell Signaling #45581), anti-caspase 1 (Abclonal #A0964),

(3) EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized micePLoS pathogensJune 1, 2020Li C, Romero-Masters JC, Huebner S, Ohashi M, Hayes M, Bristol JA, Nelson SE, Eichelberg MR, Van Sciver N, Ranheim EA, et al.Signaling Technology Cs-64594 IHC CD138 Invitrogen MA-12400 IHC IRF4 Santa Cruz Biotechnology sc-56713 IHC IgG Cell Marque 269A-15 IHC IgM Cell Marque 270A-15 IHC c-Myc Abcam Inc. ab-32072 WB PDGFR Cell Signaling Technology

(4) An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse ModelJournal of virologyMay 4, 2020Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Zumwalde NA, Bristol JA, Nelson SE, Ma S, Ranheim EA, et al.

(5) B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infectionPLoS pathogensFebruary 1, 2020Romero-Masters JC, Huebner SM, Ohashi M, Bristol JA, Benner BE, Barlow EA, Turk GL, Nelson SE, Baiu DC, Van Sciver N, et al.

(6) Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B-cell lymphomaCancer medicineSeptember 1, 2018Ma XB, Zhong YP, Zheng Y, Jiang J, Wang YP.

(7) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse modelPLoS pathogensAugust 1, 2018Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Bristol JA, Ma S, Ranheim EA, Gumperz J, Johannsen EC, et al.

(8) LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell deathOncotargetJanuary 19, 2018Wang L, Howell MEA, McPeak B, Riggs K, Kohne C, Yohanon JU, Foxler DE, Sharp TV, Moorman JP, Yao ZQ, et al.

(9) Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not EssentialJournal of virologyApril 1, 2017Ma SD, Tsai MH, Romero-Masters JC, Ranheim EA, Huebner SM, Bristol JA, Delecluse HJ, Kenney SC.

(10) MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomibLeukemiaDecember 1, 2015Xie Z, Bi C, Chooi JY, Chan ZL, Mustafa N, Chng WJ.membranes. The blots were probed with antibodies against c-Myc (sc-40), His-probe (sc-53073), IRF4 (sc-56713), NF-κB p65 (sc-8008), PARP (sc-8007) and β-actin (sc-69879) (Santa Cruz Biotechnology, Dallas, TX,

(11) Che-1-induced inhibition of mTOR pathway enables stress-induced autophagyThe EMBO journalMay 5, 2015Desantis A, Bruno T, Catena V, De Nicola F, Goeman F, Iezzi S, Sorino C, Ponzoni M, Bossi G, Federico V, et al.multiple myeloma cell growth sections underwent staining with IRF4/MUM1 monoclonal antibody (Santa Cruz, clone sc-56713, dil 1:1500, Ag retrieval with Tris-EDTA, pH 9, at 98°C for 10 min); slides were washed in TBS and developed

(12) CD43 expression in diffuse large B-cell lymphoma, not otherwise specified: CD43 is a marker of adverse prognosisHuman pathologyApril 1, 2015Ma XB, Zheng Y, Yuan HP, Jiang J, Wang YP.

(13) Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cellsJournal of virologySeptember 1, 2013Wang L, Ning S.

(14) Flow cytometric detection and quantification of CD56 (neural cell adhesion molecule, NCAM) expression in diffuse large B cell lymphomas and review of the literatureHistopathologyFebruary 1, 2012Stacchini A, Barreca A, Demurtas A, Aliberti S, di Celle PF, Novero D.

(15) Diffuse large B-cell lymphoma in human T-lymphotropic virus type 1 carriersLeukemia research and treatmentJanuary 1, 2012Beltran BE, Quiñones P, Morales D, Revilla JC, Alva JC, Castillo JJ.

(16) Clinical significance and prognosis of MYC translocation in diffuse large B-cell lymphomaHematological oncologyDecember 1, 2011Zhang HW, Chen ZW, Li SH, Bai W, Cheng NL, Wang JF.

(17) Clinical Impact of t(14;18) in Diffuse Large B-cell LymphomaChinese journal of cancer research = Chung-kuo yen cheng yen chiuJune 1, 2011Zhang HW, Cheng NL, Chen ZW, Wang JF, Li SH, Bai W.

(18) Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genesLeukemia researchAugust 1, 2008Kikuchi A, Nakamura N, Kuze T, Sasaki Y, Abe M, Ohno H, Akasaka T, Nakamura S, Ohshima K, Ando K.

(19) Composite marginal zone B-cell lymphoma and classical Hodgkin''s lymphoma: a clinicopathological study of 12 casesHistopathologyFebruary 1, 2005Zettl A, Rüdiger T, Marx A, Müller-Hermelink HK, Ott G.

(20) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cellsBloodMarch 15, 2000Falini B, Fizzotti M, Pucciarini A, Bigerna B, Marafioti T, Gambacorta M, Pacini R, Alunni C, Natali-Tanci L, Ugolini B, et al.

Be the First to Write a Review!

IRF-4 (MUM1p) Antibody

IRF-4 (MUM1p) Antibody from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (21)

Reviews

IRF-4 (MUM1p) Antibody from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map